Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus in Myasthenia Gravis Insufficiently Treated by Glucocorticoids
NCT01325571Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2011
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myasthenia gravis (MG) comparing Tacrolimus Group with Placebo Group (2 arms). Primary endpoint: Quantitative Myasthenia Gravis Score at 24 weeks. Started Mar 2011; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT01325571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01325571.